Production (Stage)
D
COSCIENS Biopharma Inc. CSCI
$3.57 -$0.045-1.25% NASDAQ
Recommendation
Prev Close
$3.57
Volume
1
Avg Vol (90D)
16,770
Market Cap
$11.26M
Dividend & Yield
--
52-Week Range
$1.96 - $7.54
P/E (TTM)
--
EPS (TTM)
-$3.95
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
COSCIENS Biopharma Announces Virtual Shareholder Meeting on June 30, 2025
6/9/2025 - TipRanks Financial Blog
COSCIENS Biopharma (NASDAQ:CSCI) Trading Down 1.1% - Time to Sell?
6/1/2025 - Ticker Report
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
5/30/2025 - GuruFocus
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders CSCI Stock News
5/30/2025 - GuruFocus
COSCIENS Biopharma Schedules Virtual Annual Meeting for June 30, 2025
5/30/2025 - TipRanks Financial Blog
COSCIENS Biopharma reconstitutes board
5/30/2025 - SeekingAlpha.com: All News
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
5/30/2025 - GuruFocus
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
5/30/2025 - Globe Newswire
Cosciens Biopharma announces receipt of Goodwood intended director nominations
5/27/2025 - Yahoo! Finance: News
Cosciens Biopharma announces receipt of Goodwood intended director nominations
5/26/2025 - TipRanks Financial Blog
Cosciens Biopharma announces receipt of Goodwood intended director nominations
5/26/2025 - The Fly
COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for ...
5/26/2025 - GuruFocus
COSCIENS Biopharma Receives Director Nominations from Goodwood
5/26/2025 - TipRanks Financial Blog
COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for ...
5/26/2025 - GuruFocus
COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders
5/26/2025 - Globe Newswire
Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.
5/23/2025 - CNW Group - News Releases
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
5/13/2025 - GuruFocus
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate ...
5/13/2025 - GuruFocus
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
5/13/2025 - Globe Newswire
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...
4/14/2025 - GuruFocus
COSCIENS Biopharma (CSCI) Names Anna Biehn as New CEO CSCI Stock News
4/14/2025 - GuruFocus
Cosciens Biopharma appoints Biehn as CEO
4/14/2025 - TipRanks Financial Blog
Cosciens Biopharma appoints Biehn as CEO
4/14/2025 - The Fly
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...
4/14/2025 - GuruFocus
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
4/14/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$31.14M
Total Debt (Q)
$2.23M
Total Liabilities (Q)
$21.00M
Book Value Per Share (Q)
$3.22
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
0.20
7-Day Total Return
-4.03%
30-Day Total Return
-2.46%
60-Day Total Return
4.08%
90-Day Total Return
26.44%
Year to Date Total Return
30.77%
1-Year Total Return
-44.61%
2-Year Total Return
-68.57%
3-Year Total Return
-79.51%
5-Year Total Return
-96.24%
52-week Low
Mar 13, 2025 - $1.96
52-week High
Jul 09, 2024 - $7.54
Valuation
Market Cap
$11.26M - Nano Cap
Enterprise Value
-$943.43K
Price/Sales (TTM)
1.57
Price/Book (Q)
1.11
Dividends and Shares
Shares Outstanding
3.14M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cosciensbio.com
Phone Number
Address
222 Bay Street
Suite 3000 - PO Box 53
Toronto, ON M5K 1E7
Country
Canada
Year Founded
1990
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the... more
NASDAQ 06/13/2025 3:56PM Eastern Quotes delayed